24 Dec, EOD - Indian

SENSEX 78472.87 (-0.09)

Nifty 50 23727.65 (-0.11)

Nifty Bank 51233 (-0.16)

Nifty IT 43668.9 (-0.36)

Nifty Midcap 100 57057.9 (-0.06)

Nifty Next 50 68857.25 (-0.05)

Nifty Pharma 22558.9 (-0.06)

Nifty Smallcap 100 18732.65 (0.24)

24 Dec, EOD - Global

NIKKEI 225 39130.43 (0.24)

HANG SENG 20098.29 (1.08)

S&P 6045 (1.10)

Login/Signup
LOGIN HERE
Cancel

Chemplast Sanmar Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543336 | NSE Symbol : CHEMPLASTS | ISIN : INE488A01050 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
29-Oct-2024 05-Nov-2024 Quarterly Results Quarterly Results unaudited standalone and consolidated financials- 30th Sep, 2024 (As Per BSE Announcement dated on 05.11.2024)
01-Aug-2024 07-Aug-2024 Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve the Unaudited Standalone as well as Consolidated Financial Results along with the Limited Review Report thereon of the Company for the quarter ended 30th June 2024 Un-audited results for the quarter ended 30th June, 2024 is enclosed (As per BSE Announcement Dated on 07/08/2024)
19-Jun-2024 24-Jun-2024 Raising funds through Debt Instr. Inter alia, to consider and approve the proposal to raise funds by issue of Equity Shares and/or convertible instruments including through Qualified Institutional Placement. Outcome of Board Meeting- Fund raising regarding. (As per BSE Announcement Dated on 24/06/2024)
14-May-2024 20-May-2024 Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 inter alia to consider and approve and take on record the Audited Standalone as well as Consolidated Financial Results along with the Auditors Report thereon of the Company for the quarter and year ended 31st March 2024 and Recommendation of dividend on equity shares if any for the year ended 31st March 2024. Outcome of Board Meeting 20th May, 2024 Dividend In view of the loss incurred for the FY 2023-24, the Board of Directors have not recommended any dividend on Equity Shares for the financial year 2023-24. Intimation regarding Appointment of Director. Results for the quarter and year ended 31st March, 2024 (As Per BSE Announcement dated on 20.05.2024)
02-Feb-2024 12-Feb-2024 Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve and take on record the Unaudited Standalone as well as Consolidated Financial Results of the Company along with the Limited Review Report thereon for the quarter and nine months ended 31st December 2023. Unaudited standalone and consolidated results 31st dec, 2023 is enclosed (As per BSE Announcement Dated on 12/02/2024)
25-Oct-2023 02-Nov-2023 Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve and take on record the Unaudited Standalone as well as Consolidated Financial Results of the Company along with the Limited Review Report thereon for the quarter and half year ended 30th September 2023. Unaudited standalone as well as consolidated financial results for the quarter and half year ended 30th September, 2023 is enclosed (As per BSE Announcement Dated on 02/11/2023)
02-Aug-2023 10-Aug-2023 Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve and take on record the Unaudited Standalone as well as Consolidated Financial Results along with the Limited Review Report thereon of the Company for the quarter ended 30th June 2023. Un audited standalone and consolidated financial results is enclosed (As Per BSE Announcement dated on 10.08.2023)
09-May-2023 16-May-2023 Accounts Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 inter alia to consider and approve the Audited Standalone as well as Consolidated Financial Results along with the Audit Report thereon of the Company for the quarter and financial year ended 31st March 2023 Intimation regarding Recommendation of dividend on equity shares, if any, is proposed to be considered is enclosed. (As Per BSE Announcement Dated on 12.05.2023) Audited Standalone and Consolidated Financial Statements and results of the Company for the quarter and year ended 31st March 2023 is enclosed. Outcome of Board Meeting regarding dividend is enclosed Outcome of Board Meeting- information regarding Re-constitution of Committee is enclosed Outcome of Board Meeting- Information regarding Annual General Meeting on Friday, 11th August, 2023 through Video Conference / Other Audio-Visual Means is enclosed. (As Per BSE Announcement dated on 16.05.2023)
04-Feb-2023 11-Feb-2023 Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 inter alia to consider and approve the Un-Audited Standalone as well as Consolidated Financial Results for the quarter and nine months ended 31st December 2022 is enclosed. Unaudited Financial Results for the quarter and nine months ended December 31, 2022 is enclosed. (As Per BSE Announcement Dated on 11.02.2023)
25-Oct-2022 04-Nov-2022 Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 inter alia to consider and approve and take on record the Un-Audited Standalone as well as Consolidated Financial Results along with the Limited Review Report thereon of the Company for the quarter and half year ended 30th September 2022. Un-Audited Standalone as well as Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022 together with the Limited Review Report is enclosed. (As Per BSE Announcement dated on 04.11.2022)
28-Jul-2022 05-Aug-2022 Quarterly Results Quarterly Results Un-audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2022 (As per BSE Announcement Dated on 05/08/2022)
02-May-2022 10-May-2022 Accounts Quarterly Results & Audited Results Chemplast Sanmar Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2022 ,inter alia, to consider and approve and take on record the Audited Standalone as well as Consolidated Financial Results along with the Audit Report thereon of the Company for the quarter and financial year ended 31st March, 2022. Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2022 ,inter alia, to consider and approve Update on board meeting. (As Per BSE Announcement Dated on 05-05-2022) Board approved: 1. Dividend Considering the growth plans and the consequential need to conserve resources, the Board of Directors have not recommended any dividend on Equity Shares for the financial year 2021-22. 2. Annual General Meeting The Thirty Eighth Annual General Meeting of the Company will be held on Friday, the 24th June 2022. Statutory Auditors: In terms of Section 139(2) of the Companies Act, 2013, the existing Auditors S R Batliboi & Associates LLP, on completion of their term, are not eligible for reappointment. The Board of Directors as recommended by the Audit Committee of Directors, have approved the appointment of M/s B S R & Co. LLP (Firm Registration No. 101248W/W- 100022) as the Statutory Auditors of the Company for a period of 5 years from the conclusion of the ensuing 38th Annual General Meeting till the conclusion of 43rd Annual General Meeting, subject to approval of the shareholders of the Company. (As Per BSE Bulletin Dated on 10.05.2022) Outcome of Board Meeting - Intimation pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) 2015 Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2022 (As per BSE Announcement Dated on 10/5/2022)
19-Jan-2022 28-Jan-2022 Quarterly Results Quarterly Results Chemplast Sanmar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of Chemplast Sanmar Limited ('the Company') is scheduled to be held on Friday, 28Lh January 2022,to consider and approve the Unaudited Standalone as well as Consolidated Financial Results of the Company for the Quarter ended 31sL December 2021. In continuation of our earlier letter dated January 19, 2022 and pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Un-Audited Standalone as well as Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021, together with the Limited Review Report on the above by the Statutory Auditors of the Company. Intimation of Un-audited Standalone and Consolidated Financial Results for the Quarter and nine months ended December 31, 2021, approved by the Board of Directors The Board of Directors of the Company at their meeting held today, appointed Mr N Sankar as Chairman Emeritus of the Company with immediate effect for life term on an honorary basis. (As Per BSE Announcement Dated on 28.01.2022)
20-Oct-2021 29-Oct-2021 Quarterly Results Quarterly Results In continuation of our earlier letter dated 20th October, 2021 and pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Un-Audited Standalone as well as Consolidated Financial Results of the Company for the Quarter and Half Year ended 30th September, 2021, together with the Limited Review Report on the above by the Statutory Auditors of the Company. (As Per BSE Announcement dated on 29.10.2021)
1